Tibet Weixinkang Medicine Co., Ltd.

SSE:603676.SS

11.51 (CNY) • At close June 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 295.809305.877361.126312.148317.837261.472311.77399.029350.378331.386399.12352.756315.282281.866251.849291.961207.947249.707184.61151.377129.973192.963200.969192.497154.533269.419176.977145.659154.27139.54692.046110.98277.808140.4372.891133.67379.367
Cost of Revenue 118.788144.552159.709156.612143.932121.106161.427194.754173.261155.598182.24171.532153.506125.456125.423148.538100.984141.91896.74876.94168.5197.612114.812102.61178.587153.41780.70876.90389.11663.90951.15232.32130.35451.47427.282.3120
Gross Profit 177.021161.325201.417155.536173.905140.366150.343204.275177.118175.788216.88181.224161.776156.41126.425143.422106.964107.78987.86274.43661.46495.35186.15789.88775.947116.00296.26968.75765.15475.63740.89478.66147.45588.95545.6951.36179.367
Gross Profit Ratio 0.5980.5270.5580.4980.5470.5370.4820.5120.5060.530.5430.5140.5130.5550.5020.4910.5140.4320.4760.4920.4730.4940.4290.4670.4910.4310.5440.4720.4220.5420.4440.7090.610.6330.6270.3841
Reseach & Development Expenses 22.59439.25126.52720.24525.92642.65128.48824.59117.08931.62916.62513.15411.04516.0679.7797.5714.60113.123.6352.4993.9417.1877.9577.5376.4577.6296.87415.7934.08731.6116.11616.806033.823017.440
General & Administrative Expenses 26.141-61.10582.282-15.62827.929-52.45877.626-13.75530.846-27.9575.352-9.26936.012-33.29664.102-11.04521.295-33.84116.844-10.53414.994-33.37917.421-7.46211.973-21.7813.38-10.88914.857-35.13216.79-12.36515.647-36.69218.79134.9250
Selling & Marketing Expenses 47.60619.43265.99151.03855.5564.85153.50473.33563.72777.2694.64367.53472.75185.35863.9471.25654.95161.73952.30242.62234.59554.49752.03147.73847.88472.31867.48827.14132.75134.96510.08725.7198.92723.92410.83734.9830
SG&A 73.747-41.674148.27376.9883.47912.393131.1359.5894.57349.31169.99658.265108.76252.062128.04260.21176.24727.89869.14632.08849.58821.11969.45340.27559.85850.53880.86816.25347.607-0.16726.87713.35424.574-12.76729.62871.4390
Other Expenses -14.205116.441-62.910.08141.49-0.41840.9910.242.13999.988-38.11145.0342.7860.73110.5090.88-0.1762.6720.3737.654-0.3630.2761.6050.398.440.1970.394-0.220.72815.2780.53910.5160.3711.5430.201-15.938-58.303
Operating Expenses 82.136114.018111.88997.144110.862162.865116.54133.459113.801180.927148.509116.453122.593142.287107.97102.38283.19698.27874.25561.37652.31784.91679.13970.55167.986108.21788.83444.12549.2461.53427.79142.34226.20949.95530.233-15.938-58.303
Operating Income 94.88547.30789.52858.39265.091-2.14537.67973.00366.4262.58372.79469.71841.86912.43624.20342.36723.27810.40719.76115.67613.43911.0357.59122.44614.153.3289.23828.86235.21614.20913.63738.70722.11739.9216.91135.42321.065
Operating Income Ratio 0.3210.1550.2480.1870.205-0.0080.1210.1830.190.0080.1820.1980.1330.0440.0960.1450.1120.0420.1070.1040.1030.0570.0380.1170.0920.0120.0520.1980.2280.1020.1480.3490.2840.2840.2320.2650.265
Total Other Income Expenses Net -0.548-40.856-0.751-4.13641.49-0.41840.9910.240.06220.035-0.028-0.219-0.0340.73110.5090.88-0.1762.6720.3737.654-0.3630.2761.6050.398.440.1970.394-0.220.72815.890.2810.5160.3711.369-0.13511.9940.339
Income Before Tax 94.3376.45288.77774.794106.58-2.56378.6773.24366.48822.61748.40569.49941.83413.16834.71243.24723.10213.07920.13423.3313.07611.3119.19622.83622.5893.5269.63228.64135.94429.52614.17149.22322.48841.28916.77647.41821.404
Income Before Tax Ratio 0.3190.0210.2460.240.335-0.010.2520.1840.190.0680.1210.1970.1330.0470.1380.1480.1110.0520.1090.1540.1010.0590.0460.1190.1460.0130.0540.1970.2330.2120.1540.4440.2890.2940.230.3550.27
Income Tax Expense 9.7953.5498.9716.24811.665-6.342.431-0.5126.242-3.3530.3895.442.921-0.3855.6788.4774.546-0.1534.3494.8622.1370.0312.345.6572.228-5.5171.7955.662.3695.0971.784.5522.3915.9441.82161.877-58.191
Net Income 84.5422.90379.80668.54694.9153.77676.2473.75560.24625.97148.01664.05938.91313.55329.03334.76918.55613.23215.78518.46810.9411.286.85617.1820.3629.0437.83722.98233.57524.42912.3944.67220.09635.34514.95543.32421.292
Net Income Ratio 0.2860.0090.2210.220.2990.0140.2450.1850.1720.0780.120.1820.1230.0480.1150.1190.0890.0530.0860.1220.0840.0580.0340.0890.1320.0340.0440.1580.2180.1750.1350.4030.2580.2520.2050.3240.268
EPS 0.20.0070.180.160.220.0090.180.170.140.0610.110.150.0920.0320.0630.0750.040.0340.040.0470.030.0330.020.0420.0480.0230.020.0550.080.0590.030.130.060.0950.040.120.059
EPS Diluted 0.20.0070.180.160.220.0090.180.170.140.0610.110.150.090.0320.0630.0750.040.0340.040.0470.030.0330.020.0420.0480.0230.020.0550.080.0590.030.130.060.0950.040.120.059
EBITDA 94.3896.48288.82488.31120.117-2.49692.384.98178.20934.1872.80279.61251.93322.40543.91252.16332.01820.97928.03431.84621.59218.9216.80529.31829.07130.2878.86524.63215.91414.10314.235-20.24421.24539.00115.458-22.36179.367
EBITDA Ratio 0.3190.0210.2460.2830.378-0.010.2960.2130.2230.1030.1820.2260.1650.0790.1740.1790.1540.0840.1520.210.1660.0980.0840.1520.1880.1120.050.1690.1030.1010.155-0.1820.2730.2780.212-0.1671